Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Dec 24, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.79 |
| Dec 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Dec 16, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Dec 16, 2020 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 150,899 | $4.70 |
| Dec 14, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Open market or private sale of non-derivative or derivative security | 25,696 | $5.00 |
| Dec 10, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Dec 10, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Nov 20, 2020 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
| Nov 18, 2020 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 162,473 | $4.13 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 5,000 | $3.56 |
| Nov 09, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Nov 09, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $3.78 |
| Nov 06, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 7,025 | $3.50 |
| Sep 16, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,000 | $4.24 |
| Aug 28, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | $4.08 |
| Aug 12, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 250 | $3.71 |
| Aug 12, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Aug 11, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 294 | $4.03 |
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 13,881 | $3.36 |
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 30, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,000 | $3.21 |
| Jun 25, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 24, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 15,773 | $3.21 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 4,167 | $3.35 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.